Human thymopoiesis produces polyspecific CD8(+) alpha/beta T cells responding to multiple viral antigens

Abstract
T-cell receptors (TCRs) are formed by stochastic gene rearrangements, theoretically generating >10(19) sequences. They are selected during thymopoiesis, which releases a repertoire of about 10(8) unique TCRs per individual. How evolution shaped a process that produces TCRs that can effectively handle a countless and evolving set of infectious agents is a central question of immunology. The paradigm is that a diverse enough repertoire of TCRs should always provide a proper, though rare, specificity for any given need. Expansion of such rare T cells would provide enough fighters for an effective immune response and enough antigen-experienced cells for memory. We show here that human thymopoiesis releases a large population of clustered CD8(+) T cells harboring alpha/beta paired TCRs that (i) have high generation probabilities and (ii) a preferential usage of some V and J genes, (iii) which CDR3 are shared between individuals, and (iv) can each bind and be activated by multiple unrelated viral peptides, notably from EBV, CMV, and influenza. These polyspecific T cells may represent a first line of defense that is mobilized in response to infections before a more specific response subsequently ensures viral elimination. Our results support an evolutionary selection of polyspecific alpha/beta TCRs for broad antiviral responses and heterologous immunity.
Funding Information
  • European Research Council (FP7-IDEAS-ERC-322856, TRiPoD)
  • Agence Nationale de la Recherche (ANR-11- IDEX-0004-02)
  • Fondation pour la Recherche Médicale
  • Juvenile Diabetes Research Foundation United States of America
  • Agence Nationale de la Recherche (LabEx Transimmunom)
  • Agence Nationale de la Recherche (ANR-16- RHUS- 0001)
  • Agence Nationale de la Recherche (RHU IMAP)